论文部分内容阅读
目的探讨肺表面活性物质(固尔苏)治疗和鼻塞正压给氧治疗新生儿呼吸窘迫症(NRDS)的临床疗效。方法将41例生后为NRDS的患儿,分为2组,其中1组19例给予鼻塞正压给氧治疗,另22例使用固尔苏治疗,称固尔苏组。比较2组治疗前后的临床表现、血气分析结果及胸片的变化。结果两个治疗组给氧治疗和用药6h后,3例无效,其他患儿皮肤迅速转红,治疗前后血气分析,两组比较,差异无显著意义(P>0.05),固尔苏组显效率,差异均有显著意义(P<0.05),固尔苏组并发症显著减少。结论鼻塞正压给氧治疗和肺表面活性物质治疗NRDS,均能快速、有效地改善NRDS患儿症状和体征,固尔苏治疗,效能更好。
Objective To investigate the clinical efficacy of pulmonary surfactant (Curetu) and nasal obstruction positive pressure oxygen therapy in neonatal respiratory distress syndrome (NRDS). Methods A total of 41 children with NRDS after birth were divided into two groups. One group received 19 cases of nasal obstruction positive pressure oxygen therapy and the other 22 cases treated with Guer Su-Su group, which was named as Guer Su-Su group. The clinical manifestations, blood gas analysis results and chest radiographs of two groups before and after treatment were compared. Results In the two treatment groups, the oxygen therapy and the medication were not effective for 6 hours, and the skin of other children turned red immediately. The blood gas analysis before and after treatment showed no significant difference between the two groups (P> 0.05) , The differences were significant (P <0.05), Comparsolux significantly reduced the complication. CONCLUSIONS: Nasal obstruction positive pressure oxygen therapy and pulmonary surfactant treatment of NRDS can both quickly and effectively improve the symptoms and signs of NRDS children.